Form 4: Lightbridge Director Magraw Receives Equity Grants

Lightbridge Corporation's Director Daniel B. Magraw was granted 20,000 shares of common stock through restricted and performance-based awards.

Summary

• Daniel B. Magraw, a Director of Lightbridge Corporation (LTBR), acquired 20,000 shares of common stock on August 28, 2025, through various equity grants.
• This includes 5,000 shares as Restricted Stock Awards (RSAs), vesting in three equal annual installments starting from the grant date, contingent on continued service.
• An additional 15,000 shares were granted as Performance-based Restricted Stock Awards (PSAs), vesting upon achievement of specified performance conditions and certification, also contingent on continued service.
• Any unvested PSAs will be forfeited and cancelled if performance conditions are not met by December 31, 2028.
• Following these transactions, Magraw directly beneficially owns 34,055 shares of common stock.
• Magraw also holds fully vested employee stock options for a total of 10,821 shares of common stock with exercise prices ranging from $3.82 to $55.2 and expiration dates between November 20, 2025, and December 2, 2029.

Sentiment

Score: 7

Explanation: The filing indicates a routine equity grant to a director, which is generally a positive sign of alignment between management and shareholder interests, especially with performance-based components. It does not contain any negative news or significant red flags, but also no extraordinary positive developments beyond standard compensation.

Positives

• Director Daniel B. Magraw received 20,000 shares of common stock through equity grants, aligning his interests with shareholders.
• The grants include performance-based awards, incentivizing the director to achieve specific company goals.
• The continued service requirement for vesting encourages long-term commitment from the director.

Risks

• Performance-based restricted stock awards (PSAs) are subject to forfeiture if specified performance conditions are not achieved by December 31, 2028.
• Vesting of both RSAs and PSAs is contingent on the reporting person's continued service, meaning unvested shares could be lost if service ceases.

Future Outlook

The vesting schedules for the restricted stock awards (RSAs) extend over three years, and performance-based restricted stock awards (PSAs) are tied to performance conditions that must be met by December 31, 2028, indicating a long-term incentive structure for the director.

Management Comments

• Represents a grant of restricted stock awards (RSAs). These RSAs vest in three equal installments on the first, second and third anniversaries of the date of grant, contingent on the reporting person's continued service on each such vesting date.
• Represents a grant of performance-based restricted stock awards (PSAs). These PSAs vest subject to achievement of a specified performance condition, and at the time of certification thereof, contingent on the reporting person's continued service on the certification date. PSAs that remain unvested as of December 31, 2028 (the end of the performance period) will automatically be forfeited and cancelled without consideration.
• This option is fully vested as of the date of this report.

Industry Context

Equity grants to directors and executives are a standard practice across industries, particularly in the nuclear energy and advanced reactor technology sector where long-term development cycles necessitate strong alignment of management incentives with shareholder value creation over extended periods. Performance-based awards are increasingly common to tie compensation directly to strategic achievements.

Comparison to Industry Standards

• The use of both time-based (RSAs) and performance-based (PSAs) restricted stock awards is a common compensation strategy for directors in the technology and energy sectors, similar to practices seen at companies like TerraPower or NuScale Power, aiming to balance retention with performance incentives.
• The vesting schedule for RSAs over three years is typical for director equity compensation, comparable to grants observed at other publicly traded companies in the advanced nuclear space.
• The inclusion of a specific performance period end date (December 31, 2028) for PSAs is a robust governance practice, ensuring accountability and measurable outcomes, aligning with best practices for executive compensation in high-growth, capital-intensive industries.

Corporate Governance

Related Party Transactions

• Grant of 20,000 shares of common stock (RSAs and PSAs) to Daniel B. Magraw, a director of Lightbridge Corporation, as part of his compensation.

Stakeholder Impact

• Shareholders: The equity grants align the director's financial interests with long-term shareholder value creation, particularly through performance-based awards.
• Management: The grants serve as an incentive for the director to remain with the company and contribute to its performance.

Next Steps

• Vesting of 5,000 Restricted Stock Awards (RSAs) in three equal annual installments starting from August 28, 2025.
• Vesting of 15,000 Performance-based Restricted Stock Awards (PSAs) subject to achievement of specified performance conditions and certification by December 31, 2028.

Key Dates

Recommendation

This Form 4 filing details routine equity compensation for a director, including restricted stock awards and performance-based awards. While these grants align the director's interests with shareholders and incentivize long-term performance, they do not represent a material change in the company's operational or financial outlook that would warrant a 'buy' or 'sell' recommendation. It is a standard disclosure of insider activity.

Keywords

Lightbridge Corporation, LTBR, Daniel B. Magraw, Form 4, Insider Trading, Restricted Stock Awards, Performance Stock Awards, Equity Grants, Director Compensation, Beneficial Ownership